Primary |
Breast Cancer Metastatic |
54.2% |
Product Used For Unknown Indication |
18.9% |
Breast Cancer |
10.6% |
Breast Cancer Recurrent |
4.8% |
Pain |
1.6% |
Premedication |
1.6% |
Prophylaxis |
1.3% |
Her-2 Positive Breast Cancer |
1.0% |
Metastatic Gastric Cancer |
1.0% |
Bacterial Infection |
0.6% |
Endometrial Cancer |
0.6% |
Malignant Melanoma |
0.6% |
Metastases To Liver |
0.6% |
Off Label Use |
0.6% |
Adjuvant Therapy |
0.3% |
Dry Eye |
0.3% |
Hypersensitivity |
0.3% |
Hypertension |
0.3% |
Hypothyroidism |
0.3% |
Metastases To Bone |
0.3% |
|
Death |
37.1% |
Disease Progression |
15.7% |
Vomiting |
4.3% |
Diarrhoea |
2.9% |
Malignant Neoplasm Progression |
2.9% |
Myocardial Infarction |
2.9% |
Off Label Use |
2.9% |
Pain |
2.9% |
Paraesthesia |
2.9% |
Pneumonitis |
2.9% |
Respiratory Failure |
2.9% |
Sepsis |
2.9% |
Skin Reaction |
2.9% |
Skin Toxicity |
2.9% |
Tachycardia |
2.9% |
Tremor |
2.9% |
Alopecia |
1.4% |
Blindness Transient |
1.4% |
Breast Cancer |
1.4% |
Breast Cancer Metastatic |
1.4% |
|
Secondary |
Breast Cancer Metastatic |
67.5% |
Breast Cancer |
13.6% |
Product Used For Unknown Indication |
5.5% |
Prophylaxis |
1.5% |
Neoplasm Malignant |
1.3% |
Bone Cancer |
1.1% |
Pain |
1.1% |
Vulval Cancer |
1.1% |
Her-2 Positive Breast Cancer |
0.9% |
Metastases To Lymph Nodes |
0.9% |
Premedication |
0.9% |
Metastases To Liver |
0.7% |
Nausea |
0.7% |
Vomiting |
0.6% |
Vulval Cancer Metastatic |
0.6% |
Vulvar Adenocarcinoma |
0.6% |
Adjuvant Therapy |
0.4% |
Anxiety |
0.4% |
Bacterial Infection |
0.4% |
Colorectal Cancer Metastatic |
0.4% |
|
Death |
61.4% |
Cardiotoxicity |
12.7% |
Disease Progression |
4.8% |
Pain |
2.4% |
Vitamin D Deficiency |
1.8% |
White Blood Cell Count Decreased |
1.8% |
Ejection Fraction Decreased |
1.2% |
Metastases To Central Nervous System |
1.2% |
No Therapeutic Response |
1.2% |
Papilloedema |
1.2% |
Performance Status Decreased |
1.2% |
Pneumonitis |
1.2% |
Pruritus |
1.2% |
Skin Necrosis |
1.2% |
Stomatitis |
1.2% |
Vision Blurred |
1.2% |
Vomiting |
1.2% |
Acute Febrile Neutrophilic Dermatosis |
0.6% |
Blood Potassium Decreased |
0.6% |
Breast Cancer Metastatic |
0.6% |
|
Concomitant |
Breast Cancer Metastatic |
54.2% |
Breast Cancer |
25.0% |
Product Used For Unknown Indication |
20.8% |
|
Back Pain |
16.7% |
Hypoaesthesia |
16.7% |
Oral Mucosal Discolouration |
16.7% |
Palmar-plantar Erythrodysaesthesia Syndrome |
16.7% |
Pyrexia |
16.7% |
Scleroderma |
16.7% |
|